Antibiotic |
CoNS (N=44) |
S. aureus
(N=6) |
Enterococcus (N=4) |
Acinetobacter (N=4) |
E. coli (N=2) |
P |
24 (54.5%) |
3 (50%) |
1 (25%) |
- |
- |
Ox |
24 (54.5%) |
3 (50%) |
1 (25%) |
- |
- |
G |
16(36.3%) |
2 (33.3%) |
1 (25%) |
2(50%) |
1 (50%) |
CF |
16(36.3%) |
2 (33.3%) |
1 (25%) |
2 (50%) |
1 (50%) |
LE |
5(11.3%) |
1 (16.6%) |
- |
2 (50%) |
- |
E |
16(36.3%) |
2 (33.3%) |
1 (25%) |
2 (50%) |
1 (50%) |
Co |
16(36.3%) |
2 (33.3%) |
1 (25%) |
2 (50%) |
- |
CD |
16(36.3%) |
2 (33.3%) |
1 (25%) |
2 (50%) |
- |
T |
16(36.3%) |
2 (33.3%) |
1 (25%) |
- |
- |
VA |
0% |
- |
1 (25%) |
- |
- |
CA |
- |
- |
- |
2(50%) |
1(50%) |
PIT |
- |
- |
- |
1(25%) |
0% |
I |
- |
- |
- |
1(25%) |
1(50%) |
MRP |
- |
- |
- |
1(25%) |
0% |
TIG |
- |
- |
- |
0% |
0% |
TE |
0% |
0% |
0% |
- |
- |
CL |
- |
- |
- |
0% |
0% |
LZ |
0% |
0% |
0% |
- |
- |
NT |
- |
- |
- |
1(25%) |
0% |
AK |
- |
- |
- |
2(50%) |
1(50%) |
P-penicillin, OX- Oxacillin, G-Gentamicin, CF- Ciprofloxacin, LE- Levofloxacin, E- Erythromicin, CO- Cotrimoxazole, CD- Clindamycin, T- Tetracyclin, VA- Vancomycin, CACeftazidime,
PIT- Piperacilline-Tazobactam, I-Imepenem, MRP- Meropenem, TIG-Tigecycline, CL- Colistin, LZ-Linezolid, NT- Netilmicin, AK- Amikacin |